The subventricular zone (SVZ) is one of the neurogenic niches in the adult mammalian brain. The SVZ is of interest for studies on neurogenesis and stem cell therapy. Here, we report specific transduction of ependyma and/or astrocytes by recombinant adeno-associated virus type 4 (AAV4) viral vectors. AAV4 vectors encoding b-galactosidase or eGFP were injected into the lateral ventricles of neonatal and adult C57BL/6 mouse brains. In addition, SVZ injections were conducted on adult mice. AAV4 vectors show a characteristic transduction of the ependyma independent of delivery route. However, AAV4 virus injected into the SVZ targeted GFAP positive astrocytes forming the glial tube in the SVZ and rostral migratory stream (RMS). Our results introduce AAV4 as a new tool by which to manipulate glial cells in the RMS. Gene Therapy (2005) 12, 1503-1508.
Introduction
The wall of the lateral ventricle is a major site of neurogenesis in the adult mammalian brain (for reviews see Gage ). This region contains a distinct organization of different cells types. The ependyma lines the ventricles and consists of a single layer of multiciliated cells. The subventricular zone (SVZ) is adjacent to the ependyma and contains three major cell types known as Types A, B and C cells. 4 Type B cells reside in the SVZ and the rostral migratory stream (RMS) and are glial fibrillary acidic protein (GFAP) positive. Type C cells are a transient amplifying population derived from type B cells. Type C cells give rise to type A cells, which are neuroblasts ensheathed by an astroglial tube. On reaching the subependymal zone of the olfactory bulb (OB), Type A cells differentiate into interneurons in the granule and periglomerular cell layers.
Both viral and nonviral strategies have been developed to target distinct cell populations in the lateral ventricular wall, with particular focus on resident neural progenitor cells (NPCs). Falk et al 5 found that adenovirus and VSV-G pseudotyped retroviruses delivered foreign genes into NPCs more efficiently in vitro than nonviral methods. When administered into the ventricles or the SVZ, adenovirus infected ependymal cells and NPCs respectively. 6 NPCs have also been successfully labeled with recombinant retroviruses. 7, 8 Adeno-associated virus (AAV) vectors mediate longterm stable expression and induce minimal immune responses, which make them attractive vehicles for in vivo gene transfer to NPCs. While prior work with AAV type 2 (AAV2) vectors showed poor NPC transduction following direct SVZ injection, AAV2 did successfully transduce human NPCs in vitro.
9, 10 We previously showed that AAVs possessing different capsid structures have altered tropism when introduced into the mammalian brain. 11 For example, AAV4 transduced ependyma with high efficiency when injected into the striata or lateral ventricles of adult mice. 11 In the present study, we compared the transduction profile of AAV4 introduced to the SVZ relative to direct ventricular injection. Our data show that AAV4 transduces Type B astrocytes in the SVZ, and glia overlying the RMS neural tube.
Results
Newborn mice were injected with AAV4bgal at postnatal day 0 or 1 and killed 4 weeks postinjection. bGalactosidase expression in the ependyma lining the lateral ventricles of both hemispheres and the fourth ventricle indicated successful intraventricular injections (Figure 1a and b) . Double IHC for GFAP and anti-bgalactosidase was performed to investigate if type B cells were transduced by AAV4, since SVZ-resident type B astrocytes have access to the lateral ventricle via cilia. 4 Colocalization of GFAP and b-galactosidase expression was not evident (Figure 1c) . Also, the RMS was negative for b-galactosidase activity and anti-b-galactosidase immunoreactivity (data not shown). However, sparse (o0.1%) positive cells were found in the olfactory bulb (OB; Figure 1d To test if AAV4 could transduce other cell types we introduced virus directly into the SVZ. AAV4 virus encoding eGFP (AAV4eGFP) was injected into the anterior part of the subventricular zone (SVZa). Previous studies from our lab showed that striatal injection of AAV4 transduced the ependyma with high specificity.
11 Surprisingly, 4 weeks after AAV4eGFP injection into the SVZ, robust eGFP expression was found in the ependyma, the SVZ and the RMS (Figure 3 ). The transduced cells in the SVZ were GFAP + /eGFP + (Figure 3a -c). It is noteworthy that the colocalization of eGFP and GFAP was confined to the SVZ and the RMS; transduced astrocytes were not found along the injection track or elsewhere in the brain. Interestingly, none of the transduced cells were Tuj-1 + , an immature neuronal marker expressed by migrating neuroblasts (Figure 3d-f) . However, transduced cells were in close contact with Tuj-1 + positive neuroblasts, and the arrangement of GFAP + /eGFP + cells resembled the glial tube formed by type B astrocytes. 4 No eGFP + /NeuN + cells were found in the SVZ or RMS (Figure 3g-i) . Also, we were unable to identify eGFP + cells in the OB (data not shown). Our results suggest that the subtype of astrocytes transduced by AAV4 differentiate into glial tube cells, or are resident glial tube cells at the time of injection. Our results also show that AAV4 does not transduce cells with properties consistent of NPCs. These data also support previous work by others suggesting that astrocytes in the SVZ and RMS are distinct from astroglia in other brain areas. 4 ,12,13 
Discussion
It has been established that massive migration of NPCs from the lateral ventricular wall to the OB occurs in neonatal and adult rodents. 14, 15 Although the exact number of cells added to the OB postnatally at a given time has not been determined, it is reported that over 10 000 labeled cells were observed 15 days after [ 3 H]-thymidine injection in adult mice. 15 The number is estimated to be even higher at early postnatal stages during peak migration. However, as illustrated in Figure  2 , only sparse transduced cells were found in the OB following introduction of AAV4 reporter vectors into the lateral ventricles of neonatal mice. Moreover, the majority of OB-resident transduced cells were in the SEL and were regionally and antigenically consistent with ependyma.
The cellular composition and gross structure of the lateral ventricular wall in early postnatal stages and adulthood differ. At P0, the lateral ventricular wall is composed of two compartments, the ventricular zone (VZ) contacting the lateral ventricle and the adjacent SVZ. It is reported that radial glia account for approximately 95% of all cells in the VZ, whereas ependymal cells, which are immature at P0, comprise less than 2% of the population. 16 Spassky et al 17 propose a lineage relationship between radial glia and ependymal cells. Thus, the reporter gene-positive ependyma we identified 4 weeks after the introduction of AAV4 to P0/P1 brains in our study may derive from directly transduced radial glia, immature ependyma or both. Embryonic and perinatal VZ resident radial glia possess characteristics consistent with NPCs. 3, 18, 19 Thus, it is possible that the rare b-galactosidase + /NeuN + cells in the granule cell layer derived from similarly rare transduced radial glia. A second possibility is that the b-galactosidase + cells in the granule cell layer seen 4 weeks after AAV4 delivery to neonatal ventricles arose from transduced immature ependyma in the VZ. This possibility requires that ependyma have NPC potential, 20 a controversial supposition that has little supportive data. We found only rare, isolated reporter gene-positive cells in the OB granule cell layer following AAV4 delivery to adult mice ventricles. Those cells expressed the neuronal cell marker NeuN, indicating transduction of NPCs by AAV4. It has been suggested by Johansson et al 20 that ependymal cells function as multipotent neural stem cells in adult mice. Most studies, however, suggest that Type B astrocytes in the SVZ are the bona fide adult neural stem cell. [21] [22] [23] [24] Type B cells functioning as neural stem cells contact the ventricular lumen with a single cilium. In either scenario of NPC lineage, AAV4 vectors would have physical access. Our data show that transduction of NPCs by AAV4 is rare following intraventricular injection into adult or neonatal mice brains.
The transduction profile after AAV4 introduction to the SVZ contrasts starkly the near exclusive ependymal cell transduction following ventricular delivery. Astrocytes in the SVZ and the RMS form a tube-like structure around neuroblasts. 4 ]-thymidine into mice labels type B2 rather than type B1 cells. In this study, AAV4 transduced astrocytes in the SVZ and RMS in addition to ependymal cells. The robust astroglial transduction did not correlate with transgene positive interneurons in the OB. Together with prior work our data suggest that AAV4 vectors may selectively target type B1 astrocytes when injected into the SVZ. Thus, AAV4 provides as a unique tool for transduction of specific astroglial subtypes following directed delivery to the SVZ.
Astrocytes and ependymal cells have roles in adult neurogenesis distinct from their proposed roles as NPCs. For example, in Vax-1 knockout mice, the absence of astroctyes in the RMS is accompanied by failed neuroblast migration and subsequent OB atrophy. 25 AAV4 may provide a useful tool for further understanding the role of this specific astroglial subpopulation, and the genes they express, in neuroblast migration.
Ependymal cells secrete the bone morphogenic protein (BMP) inhibitor noggin, blocking the gliogenic effects of BMPs and promoting a neuronal fate of neural stem cells. 26 Also, EGF, BDNF and CNTF can promote the proliferation of NPCs or/and affect the migration or cell fate. [27] [28] [29] The efficient ependymal cell transduction profile of AAV4 could be exploited to provide a reservoir for growth factor production. Similarly, enzymes deficient in lysosomal storage diseases could be supplied via the CSF from AAV4 transduced ependyma.
In summary, AAV4 targets two important cell types resident in the lateral ventricular wall of the brain, the ependyma and astrocytes in the SVZ and RMS. Ependymal cell transduction by AAV4 is highly efficient and independent of delivery route or animal age. On the other hand, AAV4 vectors transduce astrocytes in the SVZ and RMS only when delivered directly to the SVZ. These unique properties can be exploited for prolonged secretion of proteins into the CSF for disease therapy, or for asking fundamental biological questions about the SVZ and RMS astroctyes.
Materials and methods

Animals
C57BL/6 mice were obtained from Jackson Laboratories and from our own breeding colonies. Animal maintenance and experimental manipulations were approved by the University of Iowa Animal Care and Use Committee.
Viral vectors
AAV4 vectors were prepared by triple transfection with packaging and helper plasmids. 11 Reporter vectors used in the study contained a nucleus-targeted Escherichia coli 
Injections
Newborn C57BL/6 mice (n ¼ 8) at postnatal day 0 or day 1 were immobilized with hypothermia. AAV4 vectors (1.0 ml/animal) were injected to the right hemisphere targeting the lateral ventricle. Adult mice (4-8 weeks old) were anesthetized with ketamine/xylazine (ketamine 100-125 mg/kg, xylazine 10-12.5 mg/kg). AAV4 vectors were injected into the right lateral ventricle (n ¼ 6, 10 ml/ animal) or the SVZ (5 ml/animal; n ¼ 6) using a stereotactic apparatus. Injections were performed using a 30-gauge Hamilton syringe driven by a microinjector (Micro 1; World Precision Instruments, Sarasota, FL, USA) at 0.5 ml per minute. The coordinates for intraventricular injections were 0.4 mm rostral to the bregma, 1.0 mm lateral to midline, and at 2 mm depth to the pia surface.
The coordinates for SVZ injections were 1.0 mm rostral, 1.7 mm lateral and 2.5 mm deep.
Histochemistry and immunofluorescent staining
Animals were transcardially perfused with PBS followed by 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, at 4 weeks postinjection. The brains were postfixed in the same fixative at 41C overnight, cryoprotected in 30% sucrose for 24 h, and were frozen in OCT compound. Serial sagittal sections were cut at 16 mm thickness on a cryostat. One out of every five sections was examined. b-Galactosidase-positive cells were identified by 5-bromo-4-chloro-3-indolyl b-D-galactoside (X-Gal) staining or immunohistochemistry (IHC). IHC was performed with the following primary antibodies: Alexa 488 or Alexa 568 conjugated rabbit IgG specific for E. coli b-galactosidase antibodies at 1:150 (Biodesign International, Kennebunkport, ME, USA); biotinylated mouse monoclonal anti-NeuN at 1:100 (Chemicon, Temecular, CA, USA); and a Cy3-conjugated mouse monoclonal anti-glial fibrillary acidic protein (GFAP) at 1:2000 (Sigma, St Louis, MO, USA). Alexa 350 or Alexa 488 conjugated streptavidin was used at 1:500 (Molecular Probes, Eugene, Oregon, USA). Briefly, sections were blocked for 2 h at room temperature in PBS with 3% BSA, 0.1% Triton X-100, 5% normal goat serum and 5% normal mouse serum, then incubated overnight with primary antibodies diluted in PBS with 3% BSA and 0.1% Triton X-100 at 41C. If needed, sections were washed and incubated with secondary antibodies for 2 h at room temperature. Labeled sections were viewed by a laserscanning confocal microscope (Zeiss LSM510).
